3Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M,Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1998; 332:411-5.
4Yang Z, Krasnici N, Liischer TF. Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade. Circulation 1999; 100: 5-8.
5Haynes WG, Webb DJ. Endothelium-dependent modulation of responses to endothelin-1 in human veins. Clin Sci 1993; 84:427-33.
6Dupuis J, Stewart DJ, Cernacek P, Gosselin G. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 1796; 94: 1578-84.
7McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in congestive heart failure. Circulation 1992; 85:1374-9.
8Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994;89: 1573-9.
9Spinale FG, Walker JD, Mukherjee R, Iannini JP, Keever AT,Gallagher KP. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Circulation 1997; 95: 1918-29.
10Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves longterm survival in heart failure. Nature 1996; 384: 353-5.
